Skip to Content

Case Overview

Status:Status:Investigating
Company Name:Company Name:Alignment Healthcare, Inc.
Ticker:Ticker:ALHC
Related Attorneys:Lead Attorneys:Thomas W. Elrod
Related Practices:Related Practices:Securities
On July 8, 2026, it was reported that a former executive at Alignment Healthcare filed a whistleblower lawsuit alleging that the Company manipulated its finances to boost its stock price and executive compensation.
 
The whistleblower, who was employed by Alignment Healthcare from 2019 to 2025 and most recently served as the Company’s Chief Transformation Officer, alleges that Alignment Healthcare misclassified operating expenses as capital expenditures. These actions purportedly boosted the Company’s adjusted EBITDA for 2024 and 2025, thereby artificially inflating key performance metrics tied to both the Company’s stock price and executive compensation. On this news, the price of Alignment Healthcare shares declined by $4.02 per share, or approximately 17%, from $24.05 per share on July 7, 2026 to close at $20.03 on July 8, 2026.

Contact Us About This Case

You may share a link to this page on any of the sites listed below or send link via email: